Isolation and Characterization of a Novel Phage SaGU1 that Infects Staphylococcus aureus Clinical Isolates from

Yuzuki Shimamori1,2, Ajeng K Pramono3, Tomoe Kitao1

  • 1Department of Microbiology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan.

Current Microbiology
|February 27, 2021
PubMed

Insights

A novel bacteriophage, SaGU1, shows promise for treating Staphylococcus aureus infections in atopic dermatitis (AD). This phage effectively targets S. aureus strains from AD skin, offering a potential alternative to antibiotics.

Area of Science:

  • Microbiology
  • Virology
  • Dermatology

Background:

  • Staphylococcus aureus is a common skin colonizer that can cause atopic dermatitis (AD).
  • Antibiotic resistance necessitates alternative treatments for S. aureus infections.
  • Phage therapy presents a promising alternative to conventional antibiotic treatments.

Purpose of the Study:

  • To characterize the bacteriophage SaGU1 as a potential therapeutic agent against S. aureus.
  • To evaluate SaGU1's efficacy in targeting S. aureus strains from atopic dermatitis patients.
  • To assess the safety and host range of SaGU1 for potential phage therapy applications.

Main Methods:

  • Screening of bacteriophages from sewage samples.
  • Genomic sequencing and bioinformatics analysis of bacteriophage SaGU1.
  • Electron microscopy for morphology determination.
  • Lytic activity, stability, and host range assays.

Main Results:

  • SaGU1 possesses a 140,909 bp genome with 225 protein-coding genes and no toxic or antibiotic resistance genes.
  • Electron microscopy identified SaGU1 as belonging to the Myoviridae family.
  • SaGU1 demonstrated stability under physiological and acidic conditions.
  • SaGU1 exhibited broad-spectrum lytic activity against S. aureus clinical isolates from AD patients, sparing Staphylococcus epidermidis.

Conclusions:

  • Bacteriophage SaGU1 is a heat-stableMyoviridae phage with a broad host range against S. aureus relevant to atopic dermatitis.
  • SaGU1 lacks undesirable genes, indicating its safety for therapeutic use.
  • SaGU1 represents a promising candidate for developing phage therapy against S. aureus-associated atopic dermatitis.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
The Skin Microbiota01:27

The Skin Microbiota

The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...